Access the full text.
Sign up today, get DeepDyve free for 14 days.
W. Peters, P. Liu, R. Barrett, R. Stock, B. Monk, J. Berek, L. Souhami, P. Grigsby, W. Gordon, D. Alberts (2000)
Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early-stage cancer of the cervix.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 18 8
Ferlay J, Soerjomataram I, Ervik M
GLOBOCAN 2012 v1
Pearcey R, Brundage M, Drouin P
Phase III trial comparing radical radiotherapy with and without cisplatin chemotherapy in patients with advanced squamous cell cancer of the cervix
Buhlmann P, Yu B
Analyzing bagging
US Census Bureau
Census Bureau Regions and Divisions of the United States
Chad Tang, D. Gomez, Hongmei Wang, L. Levy, Y. Zhuang, T. Xu, Q. Nguyen, R. Komaki, Z. Liao (2014)
Association between white blood cell count following radiation therapy with radiation pneumonitis in non-small cell lung cancer.International journal of radiation oncology, biology, physics, 88 2
T. Keane, A. Fyles, B. O'Sullivan, M. Barton, E. Maki, J. Simm (1992)
The effect of treatment duration on local control of squamous carcinoma of the tonsil and carcinoma of the cervixSeminars in Radiation Oncology, 2
Perez CA, Grigsby PW, Castro-Vita H
Carcinoma of the uterine cervix: I
J. Grant, S. Shirvani, Chad Tang, A. Juloori, Neal Rebueno, P. Allen, Joe Chang (2015)
Incidence and predictors of severe acute esophagitis and subsequent esophageal stricture in patients treated with accelerated hyperfractionated chemoradiation for limited-stage small cell lung cancer.Practical radiation oncology, 5 4
A. Kaseb, Jeffrey Morris, Manal Hassan, Adnan Siddiqui, E. Lin, Lianchun Xiao, E. Abdalla, J. Vauthey, T. Aloia, S. Krishnan, J. Abbruzzese (2011)
Clinical and prognostic implications of plasma insulin-like growth factor-1 and vascular endothelial growth factor in patients with hepatocellular carcinoma.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 29 29
Manders DB, Moron A, McIntire D
Locally advanced cervical cancer: Outcomes with variable adherence to treatment
Suisui Song, S. Rudra, Michael Hasselle, P. Dorn, L. Mell, A. Mundt, S. Yamada, N. Lee, Y. Hasan (2013)
The effect of treatment time in locally advanced cervical cancer in the era of concurrent chemoradiotherapyCancer, 119
D. Hui, K. Hess, Renata Santos, G. Chisholm, E. Bruera (2015)
A diagnostic model for impending death in cancer patients: Preliminary reportCancer, 121
R. Deyo, D. Cherkin, D. Cherkin, M. Ciol (1992)
Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases.Journal of clinical epidemiology, 45 6
Strobl C, Malley J, Tutz G
An introduction to recursive partitioning: Rationale, application, and characteristics of classification and regression trees, bagging, and random forests
Therneau TM, Atkinson EJ (2015)
An introduction to recursive partitioning using the RPART routines
R. Mazeron, P. Castelnau-Marchand, I. Dumas, Eleonor Campo, L. Kom, F. Martinetti, G. Farha, Anne Tailleur, P. Morice, Cyrus Chargari, D. Lefkopoulos, C. Haie-meder (2015)
Impact of treatment time and dose escalation on local control in locally advanced cervical cancer treated by chemoradiation and image-guided pulsed-dose rate adaptive brachytherapy.Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology, 114 2
T. Hothorn, B. Lausen, A. Benner, M. Radespiel-Tröger (2002)
Bagging survival treesStatistics in Medicine, 23
A. Tergas, A. Neugut, Ling Chen, W. Burke, D. Hershman, J. Wright (2016)
Radiation Duration in Women with Cervical Cancer Treated with Primary Chemoradiation: A Population-Based AnalysisCancer Investigation, 34
H. Keys, Brian Bundy, F. Stehman, L. Muderspach, W. Chafe, C. Suggs, J. Walker, D. Gersell (1999)
Cisplatin, radiation, and adjuvant hysterectomy compared with radiation and adjuvant hysterectomy for bulky stage IB cervical carcinoma.The New England journal of medicine, 340 15
Peter Rose, Brian Bundy, Edwin Watkins, J. Thigpen, Gunther Deppe, Mitchell Maiman, D. Clarke‐Pearson, Sam Insalaco (1999)
Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer.The New England journal of medicine, 340 15
R. Simon, J. Subramanian, Ming-Chung Li, Supriya Menezes (2011)
Using cross-validation to evaluate predictive accuracy of survival risk classifiers based on high-dimensional dataBriefings in bioinformatics, 12 3
C. Perez, P. Grigsby, H. Castro-Vita, M. Lockett (1995)
Carcinoma of the uterine cervix. I. Impact of prolongation of overall treatment time and timing of brachytherapy on outcome of radiation therapy.International journal of radiation oncology, biology, physics, 32 5
H. Blockeel, Jan Struyf (2001)
Efficient Algorithms for Decision Tree Cross-validationArXiv, cs.LG/0110036
Mosteller F, Tukey JW
Data analysis, including statistics, in Lindzey G, Aronson E (eds): Handbook of Social Psychology
Zhibin Huang, N. Mayr, M. Gao, S. Lo, Jian Wang, G. Jia, W. Yuh (2009)
Onset time of tumor repopulation for cervical cancer: first evidence from clinical data.International journal of radiation oncology, biology, physics, 84 2
B. Jones, R. Dale (2005)
The potential for mathematical modelling in the assessment of the radiation dose equivalent of cytotoxic chemotherapy given concomitantly with radiotherapy.The British journal of radiology, 78 934
J. Geh, S. Bond, S. Bentzen, R. Glynne-Jones (2006)
Systematic overview of preoperative (neoadjuvant) chemoradiotherapy trials in oesophageal cancer: evidence of a radiation and chemotherapy dose response.Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology, 78 3
T. Girinsky, A. Rey, B. Roche, C. Haie, A. Gerbaulet, Harizo Randrianarivello, D. Chassagne (1993)
Overall treatment time in advanced cervical carcinomas: a critical parameter in treatment outcome.International journal of radiation oncology, biology, physics, 27 5
Greene FL, Page DL, Fleming ID (eds)
AJCC Cancer Staging Manual (ed 6)
C. Murphy, T. Galloway, E. Handorf, B. Egleston, Lora Wang, R. Mehra, D. Flieder, J. Ridge (2016)
Survival Impact of Increasing Time to Treatment Initiation for Patients With Head and Neck Cancer in the United States.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 34 2
C. Whitney, W. Sause, B. Bundy, J. Malfetano, E. Hannigan, W. Fowler, D. Clarke‐Pearson, S. Liao (1999)
Randomized comparison of fluorouracil plus cisplatin versus hydroxyurea as an adjunct to radiation therapy in stage IIB-IVA carcinoma of the cervix with negative para-aortic lymph nodes: a Gynecologic Oncology Group and Southwest Oncology Group study.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 17 5
M. Morris, P. Eifel, Jiandong Lu, P. Grigsby, C. Levenback, R. Stevens, M. Rotman, D. Gershenson, D. Mutch (1999)
Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer.The New England journal of medicine, 340 15
Youssef E, Forman JD, Tekyi-Mensah S
Therapeutic postprostatectomy irradiation
D. Citterio, A. Facciorusso, C. Sposito, Roberta Rota, S. Bhoori, V. Mazzaferro (2016)
Hierarchic Interaction of Factors Associated With Liver Decompensation After Resection for Hepatocellular Carcinoma.JAMA surgery, 151 9
L. Krebs, S. Maillard, N. Gaillot-petit, C. Ortholan, T. Nguyen (2015)
Total radiation dose and overall treatment time are predictive for tumor sterilization in cervical carcinoma treated with chemoradiation and pulsed-dose-rate brachytherapy.Brachytherapy, 14 1
National Comprehensive Cancer Network (NCCN)
NCCN Guidelines: Clinical Practice Guidelines in Oncology, Cervical Cancer Version 1
American College of Surgeons
About the National Cancer Database
Y. Nishimura (2004)
Rationale for chemoradiotherapyInternational Journal of Clinical Oncology, 9
Shang-Wen Chen, J. Liang, S. Yang, H. Ko, F. Lin (2003)
The adverse effect of treatment prolongation in cervical cancer by high-dose-rate intracavitary brachytherapy.Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology, 67 1
S. Roach, A. Steenbeek, M. Abdolell, R. Urquhart, G. Johnston (2014)
What is the data-defined length for short time from diagnosis to death that is associated with a low rate of palliative care enrolment for persons with colorectal cancer?BMJ Supportive & Palliative Care, 4
Daniel Ho, K. Imai, Gary King, E. Stuart (2011)
MatchIt: Nonparametric Preprocessing for Parametric Causal InferenceJournal of Statistical Software, 42
D. Petereit, J. Sarkaria, R. Chappell, J. Fowler, T. Hartmann, T. Kinsella, J. Stitt, B. Thomadsen, D. Buchler (1995)
The adverse effect of treatment prolongation in cervical carcinoma.International journal of radiation oncology, biology, physics, 32 5
Kurland BF, Peterson LM, Lee JH
Estrogen receptor binding (18F-FES PET) and glycolytic activity (18F-FDG PET) predict progression-free survival on endocrine therapy in patients with ER+ breast cancer
N. Shaverdian, V. Gondi, Kathryn Sklenar, Emily Dunn, D. Petereit, M. Straub, K. Bradley (2013)
Effects of treatment duration during concomitant chemoradiation therapy for cervical cancer.International journal of radiation oncology, biology, physics, 86 3
R. Lanciano, T. Pajak, K. Martz, G. Hanks (1993)
The influence of treatment time on outcome for squamous cell cancer of the uterine cervix treated with radiation: a patterns-of-care study.International journal of radiation oncology, biology, physics, 25 3
M. Dixon, J. Haukoos, S. Udani, J. Naghi, T. Arnell, Ravin Kumar, M. Stamos (2003)
Carcinoembryonic antigen and albumin predict survival in patients with advanced colon and rectal cancer.Archives of surgery, 138 9
Ho DE, Imai K, King G
Matching as nonparametric preprocessing for reducing model dependence in parametric causal inference
Breiman L
Bagging predictors, 421
A. Buja, W. Stuetzle (2006)
OBSERVATIONS ON BAGGINGStatistica Sinica, 16
A. Fyles, T. Keane, M. Barton, Janis Simm (1992)
The effect of treatment duration in the local control of cervix cancer.Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology, 25 4
M. Zelefsky, D. Kuban, L. Levy, L. Potters, D. Beyer, J. Blasko, B. Moran, J. Ciezki, A. Zietman, T. Pisansky, M. Elshaikh, E. Horwitz (2007)
Multi-institutional analysis of long-term outcome for stages T1-T2 prostate cancer treated with permanent seed implantation.International journal of radiation oncology, biology, physics, 67 2
Purpose: Prior studies have demonstrated the importance of treatment duration (TD) in radiation therapy (RT) for cervical cancer, with an 8-week goal based primarily on RT alone. This study uses a contemporary cohort to estimate the time point by which completion of chemoradiation therapy is most critical. Patients and Methods: The National Cancer Database was queried for women with nonmetastatic cervical cancer diagnosed from 2004 to 2012 who underwent chemotherapy, external beam RT, and brachytherapy. Data-derived TD cut points for overall survival (OS) were computed by using recursive partitioning analysis with bootstrapped aggregation (bagging) and 10-fold cross-validation. Models were independently trained with 70% of the population and validated on 30% of the population by log-rank test with and without propensity matching. Multivariable Cox proportional hazards regression was performed for the entire cohort. Results: In all, 7,355 women were identified with a median TD of 57 days. Bagged recursive partitioning analysis converged to a mean cut point of 66.6 days (median, 64.5 days; interquartile range, 63.5 to 68.5 days). Cross-validation yielded a cut point of 63.3 days. Both cut points differentiated OS in validation. Younger age, recent diagnosis, geographic region, nongovernment insurance, shorter distance to treatment facility, metropolitan location, lower comorbidity, squamous cell carcinoma, lower stage, negative lymph nodes, and shorter TD were independently associated with longer OS. With adjustment, TD within the mean cut point (64.9 days; hazard ratio, 0.79; 95% CI, 0.73 to 0.87) and 56 days (hazard ratio, 0.87; 95% CI, 0.80 to 0.95) were associated with longer OS. Exploratory stratification suggested increasing OS detriment beyond 64 days. Conclusion: Shorter chemoradiation TD in cervical cancer is associated with longer survival, and TD should be minimized as much as possible. The data-derived cut point was distributed around 64 days, with a continuous relationship between shorter TD and longer OS.
JCO Clinical Cancer Informatics – Wolters Kluwer Health
Published: Mar 28, 2017
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.